Gavoille A, Nourredine M, Rollot F, Casey R, Mathey G, Kerbrat A, Ciron J, De Sèze J, Stankoff B, Maillart E, Ruet A, Labauge P, Kwiatkowski A, Zephir H, Papeix C, Defer G, Lebrun-Frenay C, Moreau T, Laplaud DA, Berger E, Clavelou P, Thouvenot E, Heinzlef O, Pelletier J, Al Khedr A, Casez O, Bourre B, Wahab A, Magy L, Moulin S, Camdessanché JP, Doghri I, Sarov M, Hankiewicz K, Pottier C, Dos Santos A, Manchon E, Tchikviladze M, Rabilloud M, Subtil F, Vukusic S. Target trial emulation to replicate randomised clinical trials using registry data in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2026 Jan 13;97(2):165-174. doi: 10.1136/jnnp-2025-336762. PMID: 40908119.
Cohen, M , Digital health in presymptomatic diseases., Rev Neurol (Paris), 2025, 181, 937-943
Soriani, MH ; Blasco, H ; Corcia, P ; Danel-Brunaud, V ; Desmaison, A ; Pradat, PF & al , Markers of presymptomatic amyotrophic lateral sclerosis: State of the art, practical implications and perspectives., Rev Neurol (Paris), 2025, 181, 893-908
Benoit, J ; Medina Villalon, S ; Lagarde, S ; Thomas, P ; Bénar, C ; Bartolomei, F , Performance of blind source separation in localizing seizure onset from routine scalp-EEG., J Neurol, 2025, 272, 7
Montalban, X ; Lebrun-Frénay, C ; Oh, J ; Arrambide, G ; Moccia, M ; Pia Amato, M & al , Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria., Lancet Neurol, 2025, 24, 850-8
Simonet, B ; Mondot, L ; Almairac, F , Awake surgery with direct electrical stimulation for safe resection of a deep posterior thalamic cavernous malformation., Neurochirurgie, 2025, 71, 101720
Lebrun-Frenay, C ; Cohen, M ; Okuda, DT , Presymptomatic multiple sclerosis: Insights from the Radiologically Isolated Syndrome., Rev Neurol (Paris), 2025, 181, 839-846
Comet, C ; Jouvenot, G ; Bourre, B ; Ciron, J ; Audoin, B ; Ayrignac, X & al , Place of anti-IL6R in the therapeutic strategy in NMOSD-AQP4+, MOGAD, and NMOSD double-seronegative patients., Mult Scler, 2025, ,13524585251396421
Mazloum, MP ; Henon, H ; Coccia, A ; Labreuche, J ; Devos, P ; Almairac, F & al , Systematic review and meta-analysis on mortality and functional outcome in patients with large cerebellar infarctions treated with neurosurgery., Int J Stroke, 2025, , 17474930251404763
Cohen, M , Digital health in presymptomatic diseases., Rev Neurol (Paris), 2025, 181, 937-943
Soriani, MH ; Blasco, H ; Corcia, P ; Danel-Brunaud, V ; Desmaison, A ; Pradat, PF & al , Markers of presymptomatic amyotrophic lateral sclerosis: State of the art, practical implications and perspectives., Rev Neurol(Paris), 2025, 181, 893-908
Nehme, A ; Sylaja, PN ; Isabel, C ; Capron, J ; Arquizan, C ; Régent, A & al , Baseline features and functional outcomes in primary central nervous system vasculitis: development and validation of a prognostic model.,Rheumatology (Oxford), 2025, ,
Benoit, J ; Medina Villalon, S ; Lagarde, S ; Thomas, P ; Bénar, C ; Bartolomei, F , Performance of blind source separation in localizing seizure onset from routine scalp-EEG., J Neurol, 2025, 272, 750
Teisseyre, M ; Allinovi, M ; Levraut, M ; Lomi, J ; Cremoni, M ; Seitz-Polski, B , [Anti-rituximab antibodies in autoimmune diseases and hematologic malignancies: An update]., Rev Med Interne, 2025, ,
Wilson, S ; Leray, E ; Calocer, F ; Rollot, F ; Fauvernier, M ; Remontet, L & al , Influence of geographical accessibility to specialist and primary care givers on excess mortality of multiple sclerosis patients in France.,BMC Neurol, 2025, 25, 441
Benoit, J ; Joubert, B ; Vogrig, A , Role of antibodies in immune checkpoint inhibitor-related CNS toxicities: insights from challenging clinical cases., J Neuroimmunol, 2025, 409, 578778
Mukesha, D ; Sarter, M ; Dubray, M ; Durand, F ; Boutillier, S ; Pham-Van, LD & al , Targeted serum metabolomic profiling and machine learning approach in Alzheimer »s disease using the Alzheimer »s disease diagnostics clinical study (ADDIA) cohort., J Alzheimers Dis, 2025, 108, 824-833
Dupré, R ; Grosse, JP ; Baillif, S ; Philippe, C ; Rabot, A ; Mondot, L & al , Orbital Apex Syndrome Secondary to Herpes Zoster Ophthalmicus: A Literature Review and In-Depth Understanding., Semin Ophthalmol, 2025, , 1-12
Montalban, X ; Lebrun-Frénay, C ; Oh, J ; Arrambide, G ; Moccia, M ; Pia Amato, M & al , Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria., Lancet Neurol, 2025, 24, 850-865
Rodrigues, MA ; Seiffge, D ; Samarasekera, N ; Moullaali, TJ ; Wardlaw, JM ; Schreiber, S & al , Association between the Edinburgh CT and genetic diagnostic criteria for cerebral amyloid angiopathy-associated lobar intracerebral haemorrhage and recurrent intracerebral haemorrhage: an individual patient data meta-analysis., Lancet Neurol, 2025, 24, 828-839
Simonet, B ; Mondot, L ; Almairac, F , Awake surgery with direct electrical stimulation for safe resection of a deep posterior thalamic cavernous malformation., Neurochirurgie, 2025, 71, 101720
Garcia, A ; Rodriguez, S ; Dugast, E ; Lebrun-Frenay, C ; Thouvenot, E ; de Sèze, J & al , Durable B-Cell Impairment While Sparing IgA B Cells After Ocrelizumab Therapy in Multiple Sclerosis., Ann Clin Transl Neurol, 2025, 12, 2271-2285
Lebrun-Frenay, C ; Cohen, M ; Okuda, DT , Presymptomatic multiple sclerosis: Insights from the Radiologically Isolated Syndrome., Rev Neurol (Paris), 2025, 181, 839-846
Lebrun-Frenay, C , Discussing with our patient a presymptomatic adult-onset neurological disease., Rev Neurol (Paris), 2025, 181, 819-820
Corcia, P ; Erazo, D ; Amador, MDM ; Beltran, S ; Bernard, E ; Blasco, H & al , Prevalence of SOD1 and C9orf72 Variants Among French ALS Population: The GENIALS Study., Eur J Neurol, 2025, 32, e70302
Gavoille, A ; Leray, E ; Marignier, R ; Rollot, F ; Casey, R ; Mathey, G & al , Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis., Neurology, 2025, 105, e213907
Paterson, L ; Elliott, RA ; Constantinidou, F ; David, R ; Dawes, P ; Frison, E & al , The Cost-Effectiveness of an Intervention to Preserve Independence in People With Dementia (Vs. No Intervention): A Decision- Analytic (Markov) Model Analysis., Int J Geriatr Psychiatry, 2025, 40, e70132
Robin, C ; Rollot, F ; Lefort, M ; Casey, R ; Vukusic, S ; Mathey, G & al , Use of Disease-Modifying Therapies in Patients With Late-Onset Multiple Sclerosis., Neurology, 2025, 105, e213744
Lebrun-Frénay, C ; Okuda, DT , High-risk populations should be screened for MS: No., Mult Scler, 2025, 31, 1034-1036
Bratu, IF ; de Clerck, L ; Catenoix, H ; Valton, L ; Aupy, J ; Nica, A & al , Cerebral Cavernous Malformations and Focal Drug-Resistant Epilepsy: Behind a Quid Pro Quo of Lesion and Epileptogenic Networks., Eur J Neurol, 2025, 32, e70276
Levraut, M ; Marignier, R ; Cohen, M ; Benoit, J ; Landes-Chateau, C ; Maillart, E & al , Relevance of Kappa and Lambda Free Light Chains in Autoimmune Astrocytopathy Associated With Anti-GFAP Antibodies., Ann Clin Transl Neurol, 2025, 12, 1785-1793
Blanc, F ; Bouteloup, V ; Paquet, C ; Chupin, M ; Pasquier, F ; Gabelle, A & al , Faster decline of very prodromal dementia with Lewy bodies when amyloid positive., Alzheimers Dement (Amst), 2025, 17, e70141
Vassallo, M ; Zerlini, M ; Fabre, R ; Joly, H ; Durant, J ; Makinson, A & al , The Effects of High-Dose Probiotic Supplementation on Immune Activation and Neurocognitive Disorders in People Living with HIV Undergoing Successful Antiretroviral Treatment: The Procog Study., Pathogens, 2025, 14,
Héraud, C ; Bresch, S ; Bourg, V ; Landes-Château, C ; Ruetsch-Chelli, C ; Ticchioni, M & al , Monitoring anti-Rituximab antibodies in myasthenia gravis affects the time to event during Rituximab treatment., J Neurol, 2025, 272, 451
Blanc, F ; Bouteloup, V ; Paquet, C ; Chupin, M ; Pasquier, F ; Gabelle, A & al , Cognitive and neuroimaging outcome of very prodromal dementia with Lewy bodies., Geroscience, 2025, ,
Desmidt, T ; Santiago-Ribeiro, MJ ; Robert, G ; Blanc, F ; de la Chapelle, SL ; David, R & al , Affective Symptoms and Amyloid Plaques: Antidepressant Response and Clinical Outcome Associated With Brain Amyloid Load in a 2-Year Cohort of Nondemented Older Adults With Depression-The ASAP Study., Am J Geriatr Psychiatry, 2025, 33, 962-973
Christensen, H ; Casolla, B ; Frontera, JA ; Grundtvig, J ; Nielsen, JD ; Petersson, J & al , Principles of reversal of anticoagulation in patients with intracerebral hemorrhage related to oral anticoagulants., Eur Stroke J, 2025, 10, 4-13
Bensimon, G ; Leigh, PN ; Tree, T ; Malaspina, A ; Payan, CA ; Pham, HP & al , Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebocontrolled trial., Lancet, 2025, 405, 1837-1850
Paoli, C ; Fabas, T ; Mondot, L ; Godfraind, C ; Dadone-Montaudié, B ; Burel-Vandenbos, F , A pineal mass in a 39-year-old woman., Brain Pathol, 2025, 35, e70012
de Boysson, H ; Nehme, A ; Briant, AR ; Alamowitch, S ; Aouba, A ; Arquizan, C & al , Data-Driven Clustering Approach to Identify Different Phenotypes of Primary Central Nervous System Vasculitis., Eur J Neurol, 2025, 32, e70174
Cohen, M ; Rollot, F ; Debouverie, M ; Zephir, H ; Vukusic, S ; De Seze, J & al , Secondary progression activity monitoring in MS despite an early highly active treatment the SPAM study., Eur J Neurol, 2025, 32, e16583
Barrit, S ; Torcida, N ; Mazeraud, A ; Boulogne, S ; Benoit, J ; Carette, T & al , Specialized Large Language Model Outperforms Neurologists at Complex Diagnosis in Blinded Case-Based Evaluation., Brain Sci, 2025, 15,
Vermersch, P ; Kwiatkowski, A ; de Sèze, J ; Créange, A ; Texier, N ; Fantoni-Quinton, S & al , Impact of Natalizumab on Productivity and Ability to Work in Patients with Multiple Sclerosis in France: The TITAN Study., Neurol Ther, 2025, 14, 895-909
Levraut, M ; Landes-Chateau, C ; Mondot, L ; Cohen, M ; Lebrun-Frenay, C , The Kappa Free Light Chains Index and Central Vein Sign: Two New Biomarkers for Multiple Sclerosis Diagnosis., Neurol Ther, 2025, 14, 711-731
Bartolomei, F ; Makhalova, J ; Benoit, J ; Lagarde, S , The different subtypes of temporal lobe seizures networks., Rev Neurol (Paris), 2025, 181, 368-381
Simon, PYR ; David, R , Alzheimer »s Disease, ?-Amyloid Peptides, and Ubiquitin-Proteasome System: Nutritherapeutic Insights., Neurodegener Dis, 2025, 25, 76-87
Staessens, S ; Vandelanotte, S ; François, O ; Boulleaux, E ; Bretzner, M ; Casolla, B & al , Association Between Thrombus Composition and Etiology in Patients With Acute Ischemic Stroke Treated by Thrombectomy., Stroke, 2025, 56, 1026-1035
Maillart, E ; Rollot, F ; Leray, E ; Benyahya, L ; Bourre, B ; Carra-Dallière, C & al , Pregnancy and birth outcomes in women with multiple sclerosis: Comparison of the RESPONSE study to the general French population., Mult Scler, 2025, 31, 324-337
Joly, H ; Brissart, H ; Fabre, R ; Cambiaggio, S ; Zerlini, M ; Honan, C & al , French validation of the Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ-23) with determination of cutoff scores: A valuable tool in clinical practice., Rev Neurol (Paris), 2025, 181, 349-362
Thouvenot, E ; Laplaud, D ; Lebrun-Frenay, C ; Derache, N ; Le Page, E ; Maillart, E & al , High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial., JAMA, 2025, 333, 1413-1422
de Sèze, J ; Labauge, P ; Liblau, R ; Martinez, M ; Moreau, T ; Suchet, L & al , LymphoTEC: a Retrospective Real-World Study on Lymphocyte Reconstitution After Lymphopenia in Patients with Multiple Sclerosis Treated with Dimethyl Fumarate in France., Adv Ther, 2025, 42, 1760-1782
Dawes, P ; Reeves, D ; Yeung, WK ; Holland, F ; Charalambous, AP ; David, R & al , Development and validation of the Montreal Cognitive Assessment for People with Vision Impairment (MOCA-VI)., Psychol Assess, 2025, 37, 114-122
Mainguy, M ; Casey, R ; Vukusic, S ; Lebrun-Frenay, C ; Berger, E ; Kerbrat, A & al , Assessing the Risk of Relapse After In Vitro Fertilization in Women With Multiple Sclerosis., Neurol Neuroimmunol Neuroinflamm, 2025, 12, e200371
Lebrun-Frenay, C , The confavreux lecture: The radiologically isolated syndrome diagnosis, prognosis and perspectives., Mult Scler, 2025, 31, 249-256
Ramdani, R ; Pique, J ; Deschamps, R ; Ciron, J ; Maillart, E ; Audoin, B & al , Evaluation of the predictive value of CSF-restricted oligoclonal bands on residual disability and risk of relapse in adult patients with MOGAD: MOGADOC study., Mult Scler, 2025, 31, 290-302
Lebrun-Frenay, C ; Kerbrat, S ; Okuda, DT ; Landes-Chateau, C ; Kantarci, OH ; Pierret, C & al , Analysis of healthcare utilization before the diagnosis of radiologically isolated syndrome., Mult Scler, 2025, 31, 184-196
Okuda, DT ; Lebrun-Frénay, C , Transforming grayscale MRI images to color utilizing generative artificial intelligence to better understand multiple sclerosis., J Cent Nerv Syst Dis, 2025, 17, 11795735241310138
Durand-Dubief, F ; Shor, N ; Audoin, B ; Bourre, B ; Cohen, M ; Kremer, S & al , MRI management of NMOSD and MOGAD: Proposals from the French Expert Group NOMADMUS., J Neuroradiol, 2025, 52, 101235
Lefort, M ; Dejardin, O ; Berger, E ; Camdessanché, JP ; Ciron, J ; Clavelou, P & al , Association between education level and access to disease-modifying treatment in patients with multiple sclerosis in France., Mult Scler, 2025, 31, 69-80
Lefort, M ; Dejardin, O ; Berger, E ; Camdessanché, JP ; Ciron, J ; Clavelou, P & al , Association between education level and disability progression in patients with multiple sclerosis in France., Mult Scler, 2025, 31, 59-68
Mazloum, MP ; Cohen, M ; Bresch, S ; Mondot, L ; Levraut, M ; Lebrun-Frenay, C , Early treatment with rituximab in Susac syndrome., Rev Neurol (Paris), 2023, ,
Scopelliti, G ; Henon, H ; Masheka-Cishesa, O ; Labreuche, J ; Kuchcinski, G ; Aboukais, R & al , Long-term cognitive outcomes after decompressive hemicraniectomy for right-hemisphere large middle cerebral artery ischemic stroke., Eur J Neurol, 2025, 32, e16492
Koch, JC ; Leha, A ; Bidner, H ; Cordts, I ; Dorst, J ; Günther, R & al , Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trial., Lancet Neurol, 2024, 23, 1133-1146
Donzé, C ; Mekies, C ; Paillot, G ; Vermersch, P ; Montagu, G ; Brechenmacher, L & al , Development of a new patient-reported outcome measure for patients with multiple sclerosis: the Multiple Sclerosis Autonomy Scale (MSAS)., Mult Scler Relat Disord, 2024, 92, 105925
Bresch, S ; Joly, H ; Colamarino, R ; Bentellis, I ; Tur, S ; Fakir, S & al , French validation of the sexual complaints screener (SCS) for patients with multiple sclerosis., Rev Neurol (Paris), 2025, 181, 85-92
Leroi, I ; Armitage, CJ ; Camacho, EM ; Charalambous, AP ; Connelly, JP ; Constantinidou, F & al , Hearing and vision rehabilitation for people with dementia in five European countries (SENSE-Cog): a randomised controlled trial., Lancet Healthy Longev, 2024, 5, 100625
Joly, H ; Gerbier, E ; Zerlini, M ; Fabre, R ; Landes-Château, C ; Mondot, L & al , Alexithymia in radiologically isolated syndrome., Mult Scler Relat Disord, 2024, 91, 105905
Scopelliti, G ; Kyheng, M ; Casolla, B ; Kuchcinski, G ; Boulouis, G ; Moulin, S & al , Depressive symptoms profile and dementia risk after spontaneous intracerebral haemorrhage., Eur Stroke J, 2025, 10, 610-617
Hay, M ; Rollot, F ; Casey, R ; Kerbrat, A ; Edan, G ; Mathey, G & al , Anti-CD20 Therapies in Drug-Naive Patients With Primary Progressive Multiple Sclerosis: A Multicenter Real-Life Study., Neurology, 2024, 103, e209886
Zeydan, B ; Azevedo, CJ ; Makhani, N ; Cohen, M ; Tutuncu, M ; Thouvenot, E & al , Early Disease-Modifying Treatments for Presymptomatic Multiple Sclerosis., CNS Drugs, 2024, 38, 973-983
Jauquet, M ; Gagnepain, P ; La Porte, E ; Thiebaut, AM ; Rochey, A ; Legros, H & al , Endogenous tPA levels: A biomarker for discriminating hemorrhagic stroke from ischemic stroke and stroke mimics., Ann Clin Transl Neurol, 2024, 11, 2877-2890
Landes-Château, C ; Ricigliano, VA ; Mondot, L ; Thouvenot, E ; Labauge, P ; Louapre, C & al , Choroid plexus enlargement correlates with periventricular pathology but not with disease activity in radiologically isolated syndrome., Mult Scler, 2024, 30, 1278-1289
Lens, C ; Demeestere, J ; Casolla, B ; Christensen, H ; Fischer, U ; Kelly, P & al , From guidelines to clinical practice in care for ischaemic stroke patients: A systematic review and expert opinion., Eur J Neurol, 2024, 31, e16417
Toumi, E ; Almairac, F ; Mondot, L ; Themelin, A ; Decoux-Poullot, AG ; Paquis, P & al , Benefit of Optical Coherence Tomography-Angiography in Patients Undergoing Transsphenoidal Pituitary Adenoma Surgery: A Prospective Controlled Study., Diagnostics (Basel), 2024, 14,
Okuda, DT ; Lebrun-Frenay, C , T2-fluid attenuated inversion recovery fat-suppressed mismatch in the identification and characterization of lesions related to radiologically isolated syndrome., BJR Case Rep, 2024, 10, uaae028
Okuda, DT ; Moog, TM ; McCreary, M ; Shan, K ; Zubkow, K ; Newton, BD & al , Dynamic Expansion and Contraction of Multiple Sclerosis T2-Weighted Hyperintense Lesions Are Present below the Threshold of Visual Perception., AJNR Am J Neuroradiol, 2025, 46, 443-450
Jougleux, C ; Joly, H ; Brissard, H ; Lenne, B ; François, S ; Hamelin, F & al , French consensus procedure for neuropsychological assessment in multiple sclerosis., Rev Neurol (Paris), 2025, 181, 58-66
Huin, V ; Blum, D ; Delforge, V ; Cailliau, E ; Djeziri, S ; Dujardin, K & al , Caffeine consumption outcomes on amyotrophic lateral sclerosis disease progression and cognition., Neurobiol Dis, 2024, 199, 106603
Benoit, J ; Squara, F ; Bourg, V ; Thomas, P , Atrial fibrillation radiofrequency ablation in a patient with vagus nerve stimulation., Neurophysiol Clin, 2024, 54, 102996
Deschamps, R ; Guillaume, J ; Ciron, J ; Audoin, B ; Ruet, A ; Maillart, E & al , Early Maintenance Treatment Initiation and Relapse Risk Mitigation After a First Event of MOGAD in Adults: The MOGADOR2 Study., Neurology, 2024, 103, e209624
Okuda, DT ; Azevedo, CJ ; Pelletier, D ; Moog, TM ; Moazami, S ; Rezvani, S & al , Dimethyl fumarate preserves brainstem and cervical spinal cord integrity in radiologically isolated syndrome., J Neurol, 2024, 271, 5899-5910
Corcia, P ; Guy, N ; Pradat, PF ; Soriani, MH ; Verschueren, A ; Couratier, P , Treatment continuity of amyotrophic lateral sclerosis with available riluzole formulations: state of the art and current challenges in a »realworld » setting., Amyotroph Lateral Scler Frontotemporal Degener, 2025, 26, 15-21
Deschamps, R ; Papeix, C ; Ayrignac, X ; Bourre, B ; Ciron, J ; Cohen, M & al , Advocating for rituximab as first-line treatment for NMOSD-AQP4 patients in France: Cost and efficacy considerations., Rev Neurol (Paris), 2024, 180, 711-714
Gavoille, A ; Rollot, F ; Casey, R ; Kerbrat, A ; Le Page, E ; Bigaut, K & al , Acute Clinical Events Identified as Relapses With Stable Magnetic Resonance Imaging in Multiple Sclerosis., JAMA Neurol, 2024, 81, 814- 823
Grangeon, L ; Boulouis, G ; Capron, J ; Bala, F ; Renard, D ; Raposo, N & al , Cerebral Amyloid Angiopathy-Related Inflammation and Biopsy-Positive Primary Angiitis of the CNS: A Comparative Study., Neurology, 2024, 103, e209548
Andriuta, D ; Roussel, M ; Chene, G ; Fischer, C ; Mangin, JF ; Dubois, B & al , The pattern of cortical thickness associated with executive dysfunction in MCI and SCC: The MEMENTO cohort., Rev Neurol (Paris), 2024, 180, 1100-1107
Theocharous, S ; Savage, G ; Charalambous, AP ; Côté, M ; David, R ; Gallant, K & al , A cross-cultural study of the Montreal Cognitive Assessment for people with hearing impairment., J Am Geriatr Soc, 2024, 72, 3156-3162
Deliktas, Y ; Derraz, I ; Finitsis, S ; Caroff, J ; Bourcier, R ; Soize, S & al , Clinical and safety outcomes of acute stenting plus thrombectomy for carotid tandem lesions with large ischemic core., J Neurointerv Surg, 2025, 17, e216-e221
Héraud, C ; Bresch, S ; Landes-Château, C ; Bourg, V ; Lebrun-Frenay, C , Rituximab alone is as effective as associated with steroids on naive patients with generalized myasthenia gravis., J Neurol, 2024, 271, 5197- 5202
Benoit, J ; Martin, F ; Thomas, P , Disconjugate paroxysmal oculomotor movements in psychogenic nonepileptic seizures: A video-EEG study of three patients., Epileptic Disord, 2024, 26, 533-535
Doche, E ; Sulowski, C ; Guigonis, JM ; Graslin, F ; Casolla, B ; Hak, JF & al , How Clot Composition Influences Fibrinolysis in the Acute Phase of Stroke: A Proteomic Study of Cerebral Thrombi., Stroke, 2024, 55, 1818-1829
Hilkens, NA ; Casolla, B ; Leung, TW ; de Leeuw, FE , Stroke., Lancet, 2024, 403, 2820-2836
Lebrun-Frenay, C ; Okuda, DT , Time to move past typical syndromes in the diagnosis of multiple sclerosis., Mult Scler, 2024, 30, 1570-1572
Bula, G ; Baillif, S ; Labalette, P ; Martel, P ; De Massary, M ; Ghetemme, C & al , [Contribution of technological aids to the extraction of orbital foreign bodies]., J Fr Ophtalmol, 2024, 47, 104190
Bartak, H ; Fareh, T ; Ben Othman, N ; Viard, D ; Cohen, M ; Rocher, F & al , Dental Adverse Effects of Anti-CD20 Therapies., Neurol Ther, 2024, 13, 917-930
Almairac, F ; Parker, D ; Mondot, L ; Isan, P ; Onno, M ; Papadopoulo, T & al , Improvement of diffusion tensor imaging-based tractography by free-water correction in nonedematous gliomas: assessment with brain mapping., J Neurosurg, 2024, 141, 684-694
Okuda, DT ; Lebrun-Frénay, C , Radiologically isolated syndrome in the spectrum of multiple sclerosis., Mult Scler, 2024, 30, 630-636
Roy, JC ; Hédouin, R ; Desmidt, T ; Dam, S ; Mirea-Grivel, I ; Weyl, L & al , Quantifying Apathy in Late-Life Depression: Unraveling Neurobehavioral Links Through Daily Activity Patterns and Brain Connectivity Analysis., Biol Psychiatry Cogn Neurosci Neuroimaging, 2024, 9, 639-649
Paoli, C ; Mc Leer, A ; Boyer, J ; Mondot, L ; Dadone-Montaudié, B ; Godfraind, C & al , A 78-year-old woman with diffuse white matter infiltration and predominant involvement of bilateral temporo-parieto-occipital regions., J Cell Mol Med, 2024, 28, e18245
Makhani, N ; Lebrun-Frenay, C ; Siva, A ; Shabanova, V ; Wassmer, E ; Santoro, JD & al , The diagnostic workup of children with the radiologically isolated syndrome differs by age and by sex., J Neurol, 2024, 271, 4019-4027
Jouvenot, G ; Courbon, G ; Lefort, M ; Rollot, F ; Casey, R ; Le Page, E & al , High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS., JAMA Neurol, 2024, 81, 490- 498
Bobot, M ; Hak, JF ; Casolla, B ; Dehondt, JD ; Burtey, S ; Doche, E & al , Acute and Chronic Kidney Dysfunction and Prognosis following Thrombectomy for Ischemic Stroke., Am J Nephrol, 2024, 55, 287-297
Ottavi, M ; Toulon, P ; Casolla, B ; Martis, N , Four clinical and biological phenotypes in antiphospholipid syndrome: a cluster analysis of 174 patients with antinuclear antibody tests., Front Immunol, 2024, 15, 1361062
Collongues, N ; Durand-Dubief, F ; Lebrun-Frenay, C ; Audoin, B ; Ayrignac, X ; Bensa, C & al , Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society., Mult Scler, 2024, 30, 899-924
Androdias, G ; Noroy, L ; Psimaras, D ; Birzu, C ; Pelletier, J ; Beigneux, Y & al , Impact of Immune Checkpoint Inhibitors on the Course of Multiple Sclerosis., Neurol Neuroimmunol Neuroinflamm, 2024, 11, e200202
Benallegue, N ; Rollot, F ; Wiertlewski, S ; Casey, R ; Debouverie, M ; Kerbrat, A & al , Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis., JAMA Neurol, 2024, 81, 273-282
Jeantin, L ; Januel, E ; Labauge, P ; Maillart, E ; de Seze, J ; Zéphir, H & al , COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022., Mult Scler, 2024, 30, 381-395
Vukusic, S ; Bourre, B ; Casey, R ; Deiva, K ; Guennoc, AM ; Lebrun-Frenay, C & al , The Response Study: A French registry on pregnancy in women with MS and related disorders and their children up to 6 years- Protocol, recruitment status, and baseline characteristics., Mult Scler, 2024, 30, 216-226
Landes-Chateau, C ; Levraut, M ; Okuda, DT ; Themelin, A ; Cohen, M ; Kantarci, OH & al , The diagnostic value of the central vein sign in radiologically isolated syndrome., Ann Clin Transl Neurol, 2024, 11, 662- 672
Venet, M ; Lepine, A ; Maarouf, A ; Biotti, D ; Boutiere, C ; Casez, O & al , Control of disease activity with large extended-interval dosing of rituximab/ocrelizumab in highly active pediatric multiple sclerosis., Mult Scler, 2024, 30, 261-265
Bolzan, A ; Benoit, J ; Pizzo, F ; Makhalova, J ; Villeneuve, N ; Carron, R & al , Correspondence between scalp-EEG and stereoelectroencephalography seizure-onset patterns in patients with MRI-negative drugresistant focal epilepsy., Epilepsia Open, 2024, 9, 568-581
Scopelliti, G ; Rossi, C ; Kuchcinski, G ; Boulouis, G ; Moulin, S ; Cordonnier, C & al , Fatigue after spontaneous intracerebral haemorrhage: prevalence and associated factors., Neurol Sci, 2024, 45, 2127-2135
Roy, JC ; Desmidt, T ; Dam, S ; Mirea-Grivel, I ; Weyl, L ; Bannier, E & al , Connectivity patterns of the core resting-state networks associated with apathy in late-life depression., J Psychiatry Neurosci, 2023, 48, E404-E413
Lebrun-Frenay, C ; Kantarci, O ; Siva, A ; Azevedo, CJ ; Makhani, N ; Pelletier, D & al , Radiologically isolated syndrome., Lancet Neurol, 2023, 22, 1075-1086
Rollot, F ; Uhry, Z ; Dantony, E ; Vukusic, S ; Debouverie, M ; Le Page, E & al , Comparison of 2 Methods for Estimating Multiple Sclerosis-Related Mortality., Neurology, 2023, 101, e2483-e2496
Corcia, P ; Vourc » »h, P ; Bernard, E ; Cassereau, J ; Codron, P ; Fleury, MC & al , French National Protocol for genetic of amyotrophic lateral sclerosis., Rev Neurol (Paris), 2023, 179, 1020-1029
Landes-Chateau, C ; Levraut, M ; Cohen, M ; Sicard, M ; Papeix, C ; Cotton, F & al , Identification of demyelinating lesions and application of McDonald criteria when confronted with white matter lesions on brain MRI., Rev Neurol (Paris), 2023, 179, 1103-1110
Chiabo, J ; Kauert, A ; Casolla, B ; Contenti, J ; Nahon-Esteve, S ; Baillif, S & al , Efficacy and safety of hyperbaric oxygen therapy monitored by fluorescein angiography in patients with retinal artery occlusion., Br J Ophthalmol, 2024, 108, 956-962
Simon, PYR ; Bus, J ; David, R , [Alzheimer »s disease, amyloid-b peptides and ubiquitin-proteasome system: Therapeutic perspectives]., Med Sci (Paris), 2023, 39, 643-649
Cohen, M ; Lebrun Frenay, C , Letter to the editor on \ »new algorithmic approach for easier and faster extended disability status scale calculation\ »., Mult Scler J Exp Transl Clin, 2023, 9, 20552173231192941
Levraut, M ; Gavoille, A ; Landes-Chateau, C ; Cohen, M ; Bresch, S ; Seitz-Polski, B & al , Kappa Free Light Chain Index Predicts Disease Course in Clinically and Radiologically Isolated Syndromes., Neurol Neuroimmunol Neuroinflamm, 2023, 10,
Lebrun-Frénay, C ; Siva, A ; Sormani, MP ; Landes-Chateau, C ; Mondot, L ; Bovis, F & al , Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical Trial., JAMA Neurol, 2023, 80, 1080-1088
Bogdan, A ; Fabre, R ; Desmidt, T ; Golebiowski, J ; Topin, J ; Bethus, I & al , Different Trajectories of Apathy and Depression Among Subjective Cognitive Impairment Individuals with or without Conversion to Dementia: Results from the Memento Cohort in France., J Alzheimers Dis, 2023, 95, 415-426
Cohen, M ; Mondot, L ; Landes-Chateau, C ; Lebrun-Frenay, C , Towards a more precise rating of neurological disability in multiple sclerosis: A new automatic and linear quantification of limbs function., Mult Scler Relat Disord, 2023, 77, 104904
Grasset, L ; Planche, V ; Bouteloup, V ; Azouani, C ; Dubois, B ; Blanc, F & al , Physical activity, biomarkers of brain pathologies and dementia risk: Results from the Memento clinical cohort., Alzheimers Dement, 2023, 19, 5700-5718
Dawes, P ; Pool, J ; Charalambous, AP ; Côté, M ; David, R ; Helmer, C & al , Assessing the pool activity level (PAL) checklist for use with people with hearing and vision loss., Geriatr Nurs, 2023, 53, 1-5
Januel, E ; Hajage, D ; Labauge, P ; Maillart, E ; De Sèze, J ; Zephir, H & al , Association Between Anti-CD20 Therapies and COVID-19 Severity Among Patients With Relapsing-Remitting and Progressive Multiple Sclerosis., JAMA Netw Open, 2023, 6, e2319766
Cohen, M ; Thomel-Rocchi, O ; Siva, A ; Okuda, DT ; Karabudak, R ; Efendi, H & al , Impact of COVID-19 vaccination or infection on disease activity in a radiologically isolated syndrome cohort: The VaxiRIS study., Mult Scler, 2023, 29, 1099-1106
Otero-Romero, S ; Lebrun-Frénay, C ; Reyes, S ; Amato, MP ; Campins, M ; Farez, M & al , European Committee for Treatment and Research in Multiple Sclerosis and European Academy of Neurology consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs., Eur J Neurol, 2023, 30, 2144-2176
Otero-Romero, S ; Lebrun-Frénay, C ; Reyes, S ; Amato, MP ; Campins, M ; Farez, M & al , ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs., Mult Scler, 2023, 29, 904-925
Demuth, S ; Collongues, N ; Audoin, B ; Ayrignac, X ; Bourre, B ; Ciron, J & al , Rituximab De-escalation in Patients With Neuromyelitis Optica Spectrum Disorder., Neurology, 2023, 101, e438-e450
Traenka, C ; Lorscheider, J ; Hametner, C ; Baumgartner, P ; Gralla, J ; Magoni, M & al , Recanalization Therapies for Large Vessel Occlusion Due to Cervical Artery Dissection: A Cohort Study of the EVA-TRISP Collaboration., J Stroke, 2023, 25, 272-281
Lebrun-Frenay, C ; Okuda, DT , Presymptomatic MS or radiologically isolated syndrome should be actively monitored and treated: Yes., Mult Scler, 2023, 29, 793-795
Almairac, F ; Parker, D ; Mondot, L ; Isan, P ; Onno, M ; Papadopoulo, T & al , Free-water correction DTI-based tractography in brain tumor surgery: assessment with functional and electrophysiological mapping of the white matter., Acta Neurochir (Wien), 2023, 165, 1675-1681
Darcourt, J ; Chardin, D ; Bourg, V ; Gal, J ; Schiappa, R ; Blonski, M & al , Added value of [ 18F]FDOPA PET to the management of high-grade glioma patients after their initial treatment: a prospective multicentre study., Eur J Nucl Med Mol Imaging, 2023, 50, 2727-2735
Merindol, J ; Levraut, M ; Seitz-Polski, B ; Morand, L ; Martis, N , Diagnostic significance of antineutrophil cytoplasmic antibody (ANCA) titres: a retrospective case-control study., RMD Open, 2023, 9,
Scopelliti, G ; Karam, A ; Labreuche, J ; Bricout, N ; Marrama, F ; Diomedi, M & al , Internal carotid artery patency after mechanical thrombectomy for stroke due to occlusive dissection: Impact on outcome., Eur Stroke J, 2023, 8, 199-207
Thibault, C ; Jean-Etienne, A ; Lebrun-Frenay, C ; Cabre, P ; Drame, M ; Barnay, JL , Comparing functional impact of multiple sclerosis on two populations in France, in the Caribbean Sea and in Europe, in regard of care level., Mult Scler Relat Disord, 2023, 72, 104559
Lebrun-Frénay, C ; Okuda, DT ; Siva, A ; Landes-Chateau, C ; Azevedo, CJ ; Mondot, L & al , The radiologically isolated syndrome: revised diagnostic criteria., Brain, 2023, 146, 3431-3443
Almairac, F ; Isan, P ; Onno, M ; Papadopoulo, T ; Mondot, L ; Chanalet, S & al , Identifying subcortical connectivity during brain tumor surgery: a multimodal study., Brain Struct Funct, 2023, 228, 815-830
Garcia, A ; Dugast, E ; Shah, S ; Morille, J ; Lebrun-Frenay, C ; Thouvenot, E & al , Immune Profiling Reveals the T-Cell Effect of Ocrelizumab in Early Relapsing-Remitting Multiple Sclerosis., Neurol Neuroimmunol Neuroinflamm, 2023, 10,
Pelle, J ; Briant, AR ; Branger, P ; Derache, N ; Arnaud, C ; Lebrun-Frenay, C & al , Real-World Effectiveness of Natalizumab Extended Interval Dosing in a French Cohort., Neurol Ther, 2023, 12, 529-542
Dawes, P ; Reeves, D ; Yeung, WK ; Holland, F ; Charalambous, AP ; Côté, M & al , Development and validation of the Montreal cognitive assessment for people with hearing impairment (MoCA-H)., J Am Geriatr Soc, 2023, 71, 1485-1494
Rode, J ; Pique, J ; Maarouf, A ; Ayrignac, X ; Bourre, B ; Ciron, J & al , Time to steroids impacts visual outcome of optic neuritis in MOGAD., J Neurol Neurosurg Psychiatry, 2023, 94, 309-313
Trucchi, L ; Cohen, M ; Nahon-Esteve, S ; Lagier, J ; Leal, C ; Almairac, F & al , Optic nerve sheath fenestration: Current status in France and comparison of 6 different surgical approaches., J Fr Ophtalmol, 2023, 46, 137-147
Gavoille, A ; Rollot, F ; Casey, R ; Debouverie, M ; Le Page, E ; Ciron, J & al , Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal Inference., Neurology, 2023, 100, e1296-e1308
Ruetsch-Chelli, C ; Okuda, DT ; Rocher, F ; Tartare-Deckert, S ; Deckert, M ; Lebrun-Frenay, C , Sphingosine-1 Phosphate Receptor Modulators Increase In Vitro Melanoma Cell Line Proliferation at Therapeutic Doses Used in Patients with Multiple Sclerosis., Neurol Ther, 2023, 12, 289-302
Polet, K ; Hesse, S ; Joly, H ; Cohen, M ; Morisot, A ; Kullmann, B & al , Facial emotion impairment in multiple sclerosis is linked to modifying observation strategies of emotional faces., Mult Scler Relat Disord, 2023, 69, 104439
Sabathé, C ; Casey, R ; Vukusic, S ; Leray, E ; Mathey, G ; De Sèze, J & al , Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring system., Mult Scler, 2023, 29, 236-247
Carra-Dallière, C ; Rollot, F ; Deschamps, R ; Ciron, J ; Vukusic, S ; Audoin, B & al , Pregnancy and post-partum in patients with myelin-oligodendrocyte glycoprotein antibody-associated disease., Mult Scler, 2023, 29, 270-276
Wilson, S ; Calocer, F ; Rollot, F ; Fauvernier, M ; Remontet, L ; Tron, L & al , Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: A retrospective observational cohort study., Lancet Reg Health Eur, 2023, 24, 100542
Okuda, DT ; Kantarci, O ; Lebrun-Frénay, C ; Sormani, MP ; Azevedo, CJ ; Bovis, F & al , Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome., Ann Neurol, 2023, 93, 604-614
Levraut, M ; Laurent-Chabalier, S ; Ayrignac, X ; Bigaut, K ; Rival, M ; Squalli, S & al , Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis: A Large Multicenter Cohort Study., Neurol Neuroimmunol Neuroinflamm, 2023, 10,
Vukusic, S ; Marignier, R ; Ciron, J ; Bourre, B ; Cohen, M ; Deschamps, R & al , Pregnancy and neuromyelitis optica spectrum disorders: 2022 recommendations from the French Multiple Sclerosis Society., Mult Scler, 2023, 29, 37-51
Vukusic, S ; Carra-Dalliere, C ; Ciron, J ; Maillart, E ; Michel, L ; Leray, E & al , Pregnancy and multiple sclerosis: 2022 recommendations from the French multiple sclerosis society., Mult Scler, 2023, 29, 11-36
Benoit, J ; Muñiz-Castrillo, S ; Vogrig, A ; Farina, A ; Pinto, AL ; Picard, G & al , Early-Stage Contactin-Associated Protein-like 2 Limbic Encephalitis: Clues for Diagnosis., Neurol Neuroimmunol Neuroinflamm, 2023, 10,
Rival, M ; Thouvenot, E ; Du Trieu de Terdonck, L ; Laurent-Chabalier, S ; Demattei, C ; Uygunoglu, U & al , Neurofilament Light Chain Levels Are Predictive of Clinical Conversion in Radiologically Isolated Syndrome., Neurol Neuroimmunol Neuroinflamm, 2023, 10,
Almairac, F ; Leplus, A ; Mondot, L ; Fontaine, D , A New Noninvasive Frameless Registration System for Stereotactic Cranial Biopsy: A Technical Note., Oper Neurosurg, 2023, 24, 64-67
Allouche, J ; Cremoni, M ; Brglez, V ; Graça, D ; Benzaken, S ; Zorzi, K & al , Air pollution exposure induces a decrease in type II interferon response: A paired cohort study., EBioMedicine, 2022, 85, 104291
Lescot, L ; Lefort, M ; Leguy, S ; Le Page, E ; Vukusic, S ; Edan, G & al , Disease modifying therapies and disease activity during pregnancy and postpartum in a contemporary cohort of relapsing Multiple Sclerosis patients., Mult Scler Relat Disord, 2022, 68, 104122
Roos, I ; Malpas, C ; Leray, E ; Casey, R ; Horakova, D ; Havrdova, EK & al , Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis., Neurology, 2022, 99, e1926-e1944
Charidimou, A ; Boulouis, G ; Frosch, MP ; Baron, JC ; Pasi, M ; Albucher, JF & al , The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study., Lancet Neurol, 2022, 21, 714-725
Marrie, RA ; Allegretta, M ; Barcellos, LF ; Bebo, B ; Calabresi, PA ; Correale, J & al , From the prodromal stage of multiple sclerosis to disease prevention., Nat Rev Neurol, 2022, 18, 559-572
Leguy, S ; Lefort, M ; Lescot, L ; Michaud, A ; Vukusic, S ; Le Page, E & al , COPP-MS: COrticosteroids during the Post-Partum in relapsing Multiple Sclerosis patients., J Neurol, 2022, 269, 5571-5581
Cohen, M ; Hesse, S ; Polet, K ; Louchart de la Chapelle, S ; Morisot, A ; Bresch, S & al , Reliability of mobile video-oculography in multiple sclerosis patients using an iPad: A prospective validation study., Mult Scler Relat Disord, 2022, 64, 103944
Lefort, M ; Sharmin, S ; Andersen, JB ; Vukusic, S ; Casey, R ; Debouverie, M & al , Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis., BMC Med Res Methodol, 2022, 22, 155
Baeri, A ; Levraut, M ; Diazzi, S ; Camuzard, O ; Cegarra-Escolano, M ; Ploumellec, MA & al , A role for metformin in the treatment of Dupuytren disease?, Biomed Pharmacother, 2022, 150, 112930
Levraut, M ; Landes, C ; Mondot, L ; Cohen, M ; Bresch, S ; Brglez, V & al , Kappa Free Light Chains, Soluble Interleukin-2 Receptor, and Interleukin-6 Help Explore Patients Presenting With Brain White Matter Hyperintensities., Front Immunol, 2022, 13, 864133
Isan, P ; Mondot, L ; Casolla, B ; Fontaine, D ; Almairac, F , Post-traumatic cerebral venous sinus thrombosis associated with epidural hematoma: A challenging clinical situation., Neurochirurgie, 2022, 68, e40-e43
Demuth, S ; Guillaume, M ; Bourre, B ; Ciron, J ; Zephir, H ; Sirejacob, Y & al , Treatment regimens for neuromyelitis optica spectrum disorder attacks: a retrospective cohort study., J Neuroinflammation, 2022, 19, 62
Rollot, F ; Couturier, J ; Casey, R ; Wiertlewski, S ; Debouverie, M ; Pelletier, J & al , Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing-Remitting Multiple Sclerosis After Fingolimod Withdrawal., Neurotherapeutics, 2022, 19, 476-490
Tur, C ; Dubessy, AL ; Otero-Romero, S ; Amato, MP ; Derfuss, T ; Di Pauli, F & al , The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth
European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021., Mult Scler, 2022, 28, 1424-1456
Scopelliti, G ; Casolla, B ; Boulouis, G ; Kuchcinski, G ; Moulin, S ; Leys, D & al , Long-term anxiety in spontaneous intracerebral hemorrhage survivors., Int J Stroke, 2022, 17, 1093-1099
Papeix, C ; Castelnovo, G ; Leray, E ; Coustans, M ; Levy, P ; Visy, JM & al , Long-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE Study., Neurol Ther, 2022, 11, 633-658
Duloquin, G ; Henon, H ; Pasi, M ; Dequatre, N ; Della Schiava, L ; Kuchcinski, G & al , Challenging the diagnosis of a posterior circulation dissecting aneurysm., Neurol Sci, 2022, 43, 3415-3417
Marchal, A ; Bretzner, M ; Casolla, B ; Kyheng, M ; Labreuche, J ; Personnic, T & al , Endovascular Thrombectomy for Distal Medium Vessel Occlusions of the Middle Cerebral Artery: A Safe and Effective Procedure., World Neurosurg, 2022, 160, e234-e241
Chau, Y ; Arnoffi, P ; Mondot, L ; Diascorn, Y ; Sédat, J , Bronchial Artery Angiographic Aspects of COVID-19., J Vasc Interv Radiol, 2022, 33, 89
Marrama, F ; Kyheng, M ; Pasi, M ; Pierre Rutgers, M ; Moulin, S ; Diomedi, M & al , Early-onset delirium after spontaneous intracerebral hemorrhage., Int J Stroke, 2022, 17, 1030-1038
Capet, N ; Levraut, M ; Delourme, A ; Thomel-Rocchi, O ; Bourg, V ; Cabre, P & al , Marburg Multiple Sclerosis Variant: Complete Remission with Very Early Administration of Mitoxantrone-A Case Report., Neurol Ther, 2022, 11, 507-513
Héraud, C ; Capet, N ; Levraut, M ; Hattenberger, R ; Bourg, V ; Thomas, P & al , Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy Presenting as Mild Encephalopathy with Reversible Splenium Lesion., Neurol Ther, 2022, 11, 499-505
Scopelliti, G ; Casolla, B ; Boulouis, G ; Kuchcinski, G ; Moulin, S ; Leys, D & al , Long-term neuropsychiatric symptoms in spontaneous intracerebral haemorrhage survivors., J Neurol Neurosurg Psychiatry, 2022, 93, 232-237
Bernard-Valnet, R ; Moisset, X ; Maubeuge, N ; Lefebvre, M ; Ouallet, JC ; Roumier, M & al , CCR5 Blockade in Inflammatory PML and PML-IRIS Associated With Chronic Inflammatory Diseases » Treatments., Neurol Neuroimmunol Neuroinflamm, 2022, 9,
Casolla, B ; Cordonnier, C , Cerebral venous sinus thrombosis associated with COVID-19 vaccine-induced thrombocytopenia: Improvement in mortality rate over time., Eur J Neurol, 2022, 29, 1-2
Lebrun-Frénay, C ; Rollot, F ; Mondot, L ; Zephir, H ; Louapre, C ; Le Page, E & al , Risk Factors and Time to Clinical Symptoms of Multiple Sclerosis Among Patients With Radiologically Isolated Syndrome., JAMA Netw Open, 2021, 4, e2128271
Bala, F ; Bricout, N ; Nouri, N ; Cordonnier, C ; Henon, H ; Casolla, B , Safety and outcomes of endovascular treatment in patients with very severe acute ischemic stroke., J Neurol, 2022, 269, 2493-2502
Michel, M ; Le Page, E ; Laplaud, DA ; Wardi, R ; Lebrun, C ; Zagnoli, F & al , Cost-utility of oral methylprednisolone in the treatment of multiple sclerosis relapses: Results from the COPOUSEP trial., Rev Neurol (Paris), 2022, 178, 241-248
Sánchez van Kammen, M ; Aguiar de Sousa, D ; Poli, S ; Cordonnier, C ; Heldner, MR ; van de Munckhof, A & al , Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2
Vaccine-Induced Immune Thrombotic Thrombocytopenia., JAMA Neurol, 2021, 78, 1314-1323
Sharmin, S ; Lefort, M ; Andersen, JB ; Leray, E ; Horakova, D ; Havrdova, EK & al , Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts., CNS Drugs, 2021, 35, 1217-1232
Giovannelli, J ; Ciron, J ; Cohen, M ; Kim, HJ ; Kim, SH ; Stellmann, JP & al , A meta-analysis comparing first-line immunosuppressants in neuromyelitis optica., Ann Clin Transl Neurol, 2021, 8, 2025-2037
Tremlett, H ; Okuda, DT ; Lebrun-Frenay, C , The multiple sclerosis prodrome is just unspecific symptoms in radiologically isolated syndrome patients – No., Mult Scler, 2021, 27, 1824-1826
Courdurie, A ; Levraut, M ; Risso, K ; Boyer, J ; Martis, N , Dry Cough and Sicca Syndrome in a 51-Year-Old Congolese Man., Clin Infect Dis, 2021, 73, 933-934
Verhoeven, JI ; Pasi, M ; Casolla, B ; Hénon, H ; de Leeuw, FE ; Leys, D & al , Long-term mortality in young patients with spontaneous intracerebral haemorrhage: Predictors and causes of death., Eur Stroke J, 2021, 6, 185-193
Tanoh, IC ; Maillart, E ; Labauge, P ; Cohen, M ; Maarouf, A ; Vukusic, S & al , MSCopilot: New smartphone-based digital biomarkers correlate with Expanded Disability Status Scale scores in people with Multiple Sclerosis., Mult Scler Relat Disord, 2021, 55, 103164
Papeix, C ; Donze, C ; Lebrun-Frénay, C , Infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society., Rev Neurol (Paris), 2021, 177, 980-994
Cohen, M ; Bresch, S ; Thommel Rocchi, O ; Morain, E ; Benoit, J ; Levraut, M & al , Should we still only rely on EDSS to evaluate disability in multiple sclerosis patients? A study of inter and intra rater reliability., Mult Scler Relat Disord, 2021, 54, 103144
Benoit, J ; Martin, F ; Thomas, P , Musicogenic epilepsy with ictal asystole: a video-EEG case report., Epileptic Disord, 2021, 23, 649-654
Casolla, B , Simulation for Neurology training: Acute setting and beyond., Rev Neurol (Paris), 2021, 177, 1207-1213
Karam, A ; Bricout, N ; Khyeng, M ; Cordonnier, C ; Leclerc, X ; Henon, H & al , Safety and outcome of mechanical thrombectomy in ischaemic stroke related to carotid artery dissection., J Neurol, 2022, 269, 772-779
Bigaut, K ; Cohen, M ; Durand-Dubief, F ; Maillart, E ; Planque, E ; Zephir, H & al , How to switch disease-modifying treatments in multiple sclerosis: Guidelines from the French Multiple Sclerosis Society (SFSEP)., Mult Scler Relat Disord, 2021, 53, 103076
Andersen, JB ; Sharmin, S ; Lefort, M ; Koch-Henriksen, N ; Sellebjerg, F ; Sørensen, PS & al , The effectiveness of natalizumab vs fingolimod-A comparison of international registry studies., Mult Scler Relat Disord, 2021, 53, 103012
Corcia, P ; Lunetta, C ; Couratier, P ; Vourc » »h, P ; Gromicho, M ; Desnuelle, C & al , Familial clustering of primary lateral sclerosis and amyotrophic lateral sclerosis: Supplementary evidence for a continuum., Eur J Neurol, 2021, 28, 2780-2783
Levraut, M ; Bourg, V ; Capet, N ; Delourme, A ; Honnorat, J ; Thomas, P & al , Cerebrospinal Fluid IL-17A Could Predict Acute Disease Severity in Non-NMDA-Receptor Autoimmune Encephalitis., Front Immunol, 2021, 12, 673021
Gavotto, A ; Feuillade, V ; Bresch, S ; Guevara, N ; Mondot, L ; Almairac, F , Papilledema secondary to vestibular schwannoma: An atypical case without intracranial hypertension., Neurochirurgie, 2022, 68, 327-330
Masheka-Cishesa, O ; Kyheng, M ; Cordonnier, C ; Kuchcinski, G ; Chochoi, M ; Lejeune, JP & al , Seizures after decompressive hemicraniectomy for large middle cerebral artery territory infarcts: Incidence, associated factors, and impact on long-term outcomes., Eur J Neurol, 2021, 28, 2745-2755
Fissolo, N ; Pignolet, B ; Rio, J ; Vermersch, P ; Ruet, A ; deSèze, J & al , Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab., Neurol Neuroimmunol Neuroinflamm, 2021, 8,
Papeix, C ; Mazoyer, J ; Maillart, E ; Bensa, C ; Dubessy, AL ; Goujon, C & al , Multiple sclerosis: Is there a risk of worsening after yellow fever vaccination?, Mult Scler, 2021, 27, 2280-2283
Casolla, B , Outcomes after large decompressive craniectomy in patients with subarachnoid haemorrhages., Eur J Neurol, 2021, 28, 2145-2146
Kardous, R ; Joly, H ; Giordana, B ; Stefanini, L ; Mulliez, A ; Giordana, C & al , Functional and dysfunctional impulsivities changes after subthalamic nucleus-deep brain stimulation in Parkinson disease., Neurochirurgie, 2021, 67, 420-426
Gauthier, A ; Viel, S ; Perret, M ; Brocard, G ; Casey, R ; Lombard, C & al , Comparison of Simoa TM and Ella TM to assess serum neurofilament-light chain in multiple sclerosis., Ann Clin Transl Neurol, 2021, 8,1141-1150
Vukusic, S ; Lebrun-Frenay, C , MRI findings in blinded trials should be available to treating physicians – Yes., Mult Scler, 2021, 27, 812-813
Ruetsch-Chelli, C ; Bresch, S ; Seitz-Polski, B ; Rosenthal, A ; Desnuelle, C ; Cohen, M & al , Memory B Cells Predict Relapse in Rituximab-Treated Myasthenia Gravis., Neurotherapeutics, 2021, 18, 938-948
Otero-Romero, S ; Ascherio, A ; Lebrun-Frénay, C , Vaccinations in multiple sclerosis patients receiving disease-modifying drugs., Curr Opin Neurol, 2021, 34, 322-328
Taieb, G ; Kaphan, E ; Duflos, C ; Lebrun-Frénay, C ; Rigau, V ; Thouvenot, E & al , Hemophagocytic Lymphohistiocytosis Gene Mutations in Adult Patients Presenting With CLIPPERS-Like Syndrome., Neurol Neuroimmunol Neuroinflamm, 2021, 8,
Moisset, X ; Fouchard, AA ; Pereira, B ; Taithe, F ; Mathey, G ; Edan, G & al , Untreated patients with multiple sclerosis: A study of French expert centers., Eur J Neurol, 2021, 28, 2026-2036
Deschamps, R ; Pique, J ; Ayrignac, X ; Collongues, N ; Audoin, B ; Zéphir, H & al , The long-term outcome of MOGAD: An observational national cohort study of 61 patients., Eur J Neurol, 2021, 28, 1659-1664
Karam, A ; Casolla, B ; Ferrigno, M ; Labreuche, J ; Cordonnier, C ; Bricout, N & al , Impact of recanalisation by mechanical thrombectomy in mild acute ischemic stroke with large anterior vessel occlusion., Rev Neurol (Paris), 2021, 177, 955-963
Nir, TM ; Fouche, JP ; Ananworanich, J ; Ances, BM ; Boban, J ; Brew, BJ & al , Association of Immunosuppression and Viral Load With Subcortical Brain Volume in an International Sample of People Living With HIV., JAMA Netw Open, 2021, 4, e2031190
Roos, I ; Leray, E ; Frascoli, F ; Casey, R ; Brown, JWL ; Horakova, D & al , Determinants of therapeutic lag in multiple sclerosis., Mult Scler, 2021, 27, 1838-1851
Corcia, P ; Camu, W ; Brulard, C ; Marouillat, S ; Couratier, P ; Camdessanché, JP & al , Effect of familial clustering in the genetic screening of 235 French ALS families., J Neurol Neurosurg Psychiatry, 2021, 92, 479-484
Lionetto, L ; Ulivieri, M ; Capi, M ; De Bernardini, D ; Fazio, F ; Petrucca, A & al , Increased kynurenine-to-tryptophan ratio in the serum of patients infected with SARS-CoV2: An observational cohort study., Biochim Biophys Acta Mol Basis Dis, 2021, 1867, 166042
Vukusic, S ; Ionescu, I ; Cornu, C ; Bossard, N ; Durand-Dubief, F ; Cotton, F & al , Oral nomegestrol acetate and transdermal 17-beta-estradiol for preventing post-partum relapses in multiple sclerosis: The POPARTMUS study., Mult Scler, 2021, 27, 1458-1463
Pasi, M ; Casolla, B ; Kyheng, M ; Boulouis, G ; Kuchcinski, G ; Moulin, S & al , Long-term functional decline of spontaneous intracerebral haemorrhage survivors., J Neurol Neurosurg Psychiatry, 2021, 92, 249-254
Filipiak, P ; Almairac, F ; Papadopoulo, T ; Fontaine, D ; Mondot, L ; Chanalet, S & al , Towards linking diffusion MRI based macro- and microstructure measures with cortico-cortical transmission in brain tumor patients., Neuroimage, 2021, 226, 117567
Cohen, M ; Mondot, L ; Bucciarelli, F ; Pignolet, B ; Laplaud, DA ; Wiertlewski, S & al , BEST-MS: A prospective head-to-head comparative study of natalizumab and fingolimod in active relapsing MS., Mult Scler, 2021, 27, 1556-1563
Cohen, M ; Mondot, L ; Fakir, S ; Landes, C ; Lebrun, C , Digital biomarkers can highlight subtle clinical differences in radiologically isolated syndrome compared to healthy controls., J Neurol, 2021, 268, 1316-1322
Shor, N ; Deschamps, R ; Cobo Calvo, A ; Maillart, E ; Zephir, H ; Ciron, J & al , MRI characteristics of MOG-Ab associated disease in adults: An update., Rev Neurol (Paris), 2021, 177, 39-50
Mathais, S ; Moisset, X ; Pereira, B ; Taithe, F ; Ciron, J ; Labauge, P & al , Relapses in Patients Treated with High-Dose Biotin for Progressive Multiple Sclerosis., Neurotherapeutics, 2021, 18, 378-386
Cobo-Calvo, A ; Ruiz, A ; Rollot, F ; Arrambide, G ; Deschamps, R ; Maillart, E & al , Clinical Features and Risk of Relapse in Children and Adults with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease., Ann Neurol, 2021, 89, 30-41
Donzé, C ; Papeix, C ; Lebrun-Frenay, C , Urinary tract infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society., Rev Neurol (Paris), 2020, 176, 804-822
Pasi, M ; Casolla, B ; Kyheng, M ; Boulouis, G ; Kuchcinski, G ; Moulin, S & al , Long-term mortality in survivors of spontaneous intracerebral hemorrhage., Int J Stroke, 2021, 16, 448-455
Herpe, G ; Lederlin, M ; Naudin, M ; Ohana, M ; Chaumoitre, K ; Gregory, J & al , Efficacy of Chest CT for COVID-19 Pneumonia Diagnosis in France., Radiology, 2021, 298, E81-E87
Capet, N ; Joly, H ; Suply, C ; Mondot, L ; Cohen, M ; Lebrun-Frenay, C , Alexithymia in multiple sclerosis: Clinical and radiological correlations., Rev Neurol (Paris), 2021, 177, 302-311
Ba, K ; Casolla, B ; Caparros, F ; Bricout, N ; Della Schiava, L ; Pasi, M & al , Early epileptic seizures in ischaemic stroke treated by mechanical thrombectomy: influence of rt-PA., J Neurol, 2021, 268, 305-311
Casolla, B ; Cordonnier, C , Intracerebral haemorrhage, microbleeds and antithrombotic drugs., Rev Neurol (Paris), 2021, 177, 11-22
Vukusic, S ; Michel, L ; Leguy, S ; Lebrun-Frenay, C , Pregnancy with multiple sclerosis., Rev Neurol (Paris), 2021, 177, 180-194
Lebrun-Frenay, C ; Berestjuk, I ; Cohen, M ; Tartare-Deckert, S , Effects on Melanoma Cell Lines Suggest No Significant Risk of Melanoma Under Cladribine Treatment., Neurol Ther, 2020, 9, 599-604
Joly, H ; Capet, N ; Mondot, L ; Cohen, M ; Suply, C ; Bresch, S & al , Thalamic atrophy correlates with dysfunctional impulsivity in multiple sclerosis., Mult Scler Relat Disord, 2020, 44, 102374
Whittam, DH ; Cobo-Calvo, A ; Lopez-Chiriboga, AS ; Pardo, S ; Gornall, M ; Cicconi, S & al , Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients., Mult Scler Relat Disord, 2020, 44, 102251
Louapre, C ; Collongues, N ; Stankoff, B ; Giannesini, C ; Papeix, C ; Bensa, C & al , Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis., JAMA Neurol, 2020, 77, 1079-1088
Lebrun-Frenay, C ; Kantarci, O ; Siva, A ; Sormani, MP ; Pelletier, D ; Okuda, DT , Radiologically Isolated Syndrome: 10-Year Risk Estimate of a Clinical Event., Ann Neurol, 2020, 88, 407-417
Zereg, E ; Chaussenot, A ; Morel, G ; Bannwarth, S ; Sacconi, S ; Soriani, MH & al , Single-fiber studies for assigning pathogenicity of eight mitochondrial DNA variants associated with mitochondrial diseases., Hum Mutat, 2020, 41, 1394-1406
Maillart, E ; Durand-Dubief, F ; Louapre, C ; Audoin, B ; Bourre, B ; Derache, N & al , Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodies., J Neuroinflammation, 2020, 17, 128
de Seze, J ; Lebrun-Frenay, C , Covid-19, the pandemic war: Implication for neurologists., Rev Neurol (Paris), 2020, 176, 223-224
Levraut, M ; Legros, L ; Drappier, C ; Béné, MC ; Queyrel, V ; Raynaud, S & al , Low prevalence of JAK2 V617F mutation in patients with thrombosis and normal blood counts: a retrospective impact study., J Thromb Thrombolysis, 2020, 50, 995-1003
Poupart, J ; Giovannelli, J ; Deschamps, R ; Audoin, B ; Ciron, J ; Maillart, E & al , Evaluation of efficacy and tolerability of first-line therapies in NMOSD., Neurology, 2020, 94, e1645-e1656
Galland, J ; Martis, N ; Levraut, M ; Hani, H ; Baumann, C ; Fournier, JP & al , Impact of Simulation-Based Learning on National Ranking Medical Examination Results in France: A Randomized Trial (SimECNi Study)., Simul Healthc, 2020, 15, 259-265
Bigaut, K ; Lambert, C ; Kremer, L ; Lebrun, C ; Cohen, M ; Ciron, J & al , Atypical myelitis in patients with multiple sclerosis: Characterization and comparison with typical multiple sclerosis and neuromyelitis optica spectrum disorders., Mult Scler, 2021, 27, 232-238
Polet, K ; Hesse, S ; Cohen, M ; Morisot, A ; Joly, H ; Kullmann, B & al , Video-oculography in multiple sclerosis: Links between oculomotor disorders and brain magnetic resonance imaging (MRI)., Mult Scler Relat Disord, 2020, 40, 101969
Joly, H ; Vassallo, M ; Issaurat, M ; Fabre, R ; Pradier, C ; Lebrun-Frenay, C , Validation of a rapid and easy-to-perform screening test for neurocognitive impairment in HIV+ patients., J Neurol Sci, 2020, 410, 116664
George, IC ; El Mendili, MM ; Inglese, M ; Azevedo, CJ ; Kantarci, O ; Lebrun, C & al , Cerebellar volume loss in radiologically isolated syndrome., Mult Scler, 2021, 27, 130-133
Maillart, E ; Labauge, P ; Cohen, M ; Maarouf, A ; Vukusic, S ; Donzé, C & al , MSCopilot, a new multiple sclerosis self-assessment digital solution: results of a comparative study versus standard tests., Eur J Neurol, 2020, 27, 429-436
Vukusic, S ; Rollot, F ; Casey, R ; Pique, J ; Marignier, R ; Mathey, G & al , Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in France., JAMA Neurol, 2020, 77, 94-102
Ciron, J ; Cobo-Calvo, A ; Audoin, B ; Bourre, B ; Brassat, D ; Cohen, M & al , Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: A retrospective multicentric study., Mult Scler, 2020, 26, 936-944
